Results
24,511 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 35 |  Gilbert Ray Cisneros, Jr.DSelf |  CRNXCrinetics Pharmaceuticals, Inc. - Common StockSale | SELL | $15K – $50K |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 35 | Gilbert Ray Cisneros, Jr.DSelf | CRNXCrinetics Pharmaceuticals, Inc. - Common Stock Sale | SELL | $15K – $50K |
| Sep 4, 2026 traded Jul 30, 2026 |
| 34 | Lacerte Rene A.Director, CEO |  BILLBILL Holdings, Inc.Open-market sale | SELL | $513K 10.2K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 34 | Viozzi Vincent AnthonySr. VP & Chief Inv Officer |  DGICADONEGAL GROUP INCOpen-market sale | SELL | $44K 2,282 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 34 | Lacerte Rene A.Director, CEO | BILLBILL Holdings, Inc. Open-market sale | SELL | $769K 15.4K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 34 | Lacerte Rene A.Director, CEO | BILLBILL Holdings, Inc. Open-market sale | SELL | $547K 11.0K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 33 | Tang StanleyDirector |  DASHDoorDash, Inc.Open-market sale · 10b5-1 plan | SELL | $509K 2,265 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 33 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $516K 2,271 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 33 | Kunkel Raymond J.Chief Operating Officer |  CWBHFCharlotte's Web Holdings, Inc.Open-market purchase | BUY | $39K 137.9K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 33 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $559K 2,500 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 33 | Gilbert Ray Cisneros, Jr.DSelf |  SAILSailPoint, Inc.Purchase | BUY | $1,001 – $15K | Sep 4, 2026 traded Jul 21, 2026 |
| 32 | Gilbert Ray Cisneros, Jr.DSelf |  ALKSAlkermes plc.Purchase | BUY | $15K – $50K | Sep 4, 2026 traded Jul 30, 2026 |
| 32 | Cunningham Bradley KramerChief Technology Officer |  PAYSPaysign, Inc.Open-market sale | SELL | $23K 3,000 sh | Sep 4, 2026 traded Jun 1, 2026 |
| 32 | Gilbert Ray Cisneros, Jr.DSelf |  MSBMESABI TRUSTPurchase | BUY | $15K – $50K | Sep 4, 2026 traded Jul 31, 2026 |
| 32 | Coloma Jason VDirector, Chief Executive Officer |  MAZEMaze Therapeutics, Inc.Open-market sale | SELL | $3,325 129 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 32 | Courtney PhillipsGC and Corp. Secretary | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $567 22 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 32 | Gilbert Ray Cisneros, Jr.DSelf |  TTDTrade Desk, Inc.Purchase | BUY | $1,001 – $15K | Sep 4, 2026 traded Jul 17, 2026 |
| 32 | Bonanni Mark EmilioEVP, CRO, Commercial |  OUTOUTFRONT Media Inc.Open-market sale | SELL | $101K 3,385 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 31 | Gilbert Ray Cisneros, Jr.DSelf |  FDXFEDEX CORPSale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 21, 2026 |
| 31 | Gilbert Ray Cisneros, Jr.DSelf |  KVUEKenvue Inc.Partial sale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 17, 2026 |
| 31 | Lantheus Alpha Therapy, LLC10% Owner |  CATXPerspective Therapeutics, Inc.Open-market sale | SELL | $112K 35.8K sh | Sep 4, 2026 traded Sep 1, 2026 |
| 31 | Boyan GeorgeDirector, President |  UNTYUNITY BANCORP INC /NJ/Open-market sale | SELL | $385K 6,504 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 31 | Quirk Steven M.Chief Brokerage Officer |  HOODRobinhood Markets, Inc.Open-market sale · 10b5-1 plan | SELL | $1.58M 13.2K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 31 | Gilbert Ray Cisneros, Jr.DSelf |  PSKYParamount Skydance Corporation - Class B Common StockSale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 17, 2026 |
| 31 | Gilbert Ray Cisneros, Jr.DSelf |  UBERUber Technologies, IncPartial sale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 17, 2026 |
| 31 | Gilbert Ray Cisneros, Jr.DSelf |  PGRPROGRESSIVE CORP/OH/Partial sale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 17, 2026 |
| 31 | Gilbert Ray Cisneros, Jr.DSelf |  SMTCSEMTECH CORPPartial sale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 16, 2026 |
| 31 | Gilbert Ray Cisneros, Jr.DSelf |  ZTSZoetis Inc.Partial sale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 17, 2026 |
| 31 | Gilbert Ray Cisneros, Jr.DSelf |  RBCRBC Bearings INCPartial sale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 16, 2026 |
| 31 | Moatazedi DavidDirector, See Remarks |  EOLSEvolus, Inc.Open-market sale | SELL | $950K 105.1K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 31 | Gilbert Ray Cisneros, Jr.DSelf |  MTSIMACOM Technology Solutions Holdings, Inc.Partial sale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 16, 2026 |
| 31 | Gilbert Ray Cisneros, Jr.DSelf |  CMCSACOMCAST CORPSale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 17, 2026 |
| 31 | Gilbert Ray Cisneros, Jr.DSelf |  CRDOCredo Technology Group Holding LtdSale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 2, 2026 |
| 30 | Lacerte Rene A.Director, CEO | BILLBILL Holdings, Inc. Open-market sale | SELL | $291K 5,752 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 29 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $17K 625 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 29 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $11K 391 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 29 | Schafer Douglas M. JREVP and CIO |  MIAXMIAMI INTERNATIONAL HOLDINGS, INC.Open-market sale · 10b5-1 plan | SELL | $1.94M 48.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 29 | Holland Noel R.Director |  CLBKColumbia Financial, Inc./MD/Open-market purchase | BUY | $234 20 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 29 | Comly Barbara J.EVP, GC & Corporate Secretary | MIAXMIAMI INTERNATIONAL HOLDINGS, INC. Open-market sale · 10b5-1 plan | SELL | $1.80M 44.4K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 29 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $929 36 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 29 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $1,521 59 sh | Sep 4, 2026 traded Sep 3, 2026 |